Patents
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
08/2003
08/20/2003EP1335708A1 Controlled release metformin compositions
08/20/2003EP1335707A2 Novel formulations of carvedilol
08/20/2003EP1335706A2 Microspheres of pancreatic enzymes with high stability
08/20/2003EP1335705A2 Preparation of drug particles using evaporation precipitation into aqueous solutions
08/20/2003EP1335704A2 Implant dosage form and use thereof for the delivery of a cholesterol lowering agent
08/20/2003EP1335693A2 Composition exhibiting enhanced formulation stability and delivery of topical active ingredients
08/20/2003EP1335689A1 Loratadine transdermal device and methods
08/20/2003EP1335661A2 Production of microspheres
08/20/2003EP1255576B1 Mineral-polymer hybrid composition
08/20/2003EP1239836B1 Colloidal suspension of submicronic particles as vectors for active principles and method for preparing same
08/20/2003EP1135147B1 Method for producing medicaments from plant extracts, in a solid form of administration
08/20/2003EP1135110B1 Preparation of dry compositions soluble in the presence of water and avoiding maillard reaction in dry state and uses
08/20/2003EP1128819B1 New controlled release bead, a method of producing the same and multiple unit formulation comprising it
08/20/2003EP1075489B1 Water-soluble prodrugs of 2,6-diisopropylphenol analogues
08/20/2003EP1022950B1 Stabilised mixtures of an iodopropargyl compound and a formaldehyde donor
08/20/2003EP0998304B1 Pharmaceutical compositions comprising a basic drug, a cyclodextrin, a polymer and an acid
08/20/2003EP0943326B1 Powdery composition for nasal administration
08/20/2003EP0934058B1 Stable drug form for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereof
08/20/2003EP0877609B1 Formulation for intranasal administration
08/20/2003EP0876109B1 Water dispersible compositions containing natural hydrophobic pigment, method of preparing same and their use
08/20/2003EP0865288B1 Bioartificial devices and cellular matrices therefor
08/20/2003EP0794786B1 The use of inositoltrisphosphate for the preparing of medicaments
08/20/2003EP0734724B1 Process for the preparation of a phencynonate hydrochloride of alpha-configuration
08/20/2003EP0679401B1 Composition for curing lesioned tissue, process for producing the same, and use thereof
08/20/2003CN2566851Y Nano-insulin oral preparation
08/20/2003CN1437634A The preparation method of a stable polymer aqueous phase-aqueous phase emulsion and its use
08/20/2003CN1437611A 糖肽膦酸盐衍生物 Glycopeptide phosphonate derivatives
08/20/2003CN1437531A Nucleated molded article, method of producing the same, and device for producing the same
08/20/2003CN1437491A Osmotic beneficial agent delivery system
08/20/2003CN1437483A Oral preparations for diabetes
08/20/2003CN1437482A Recombinant or purified polyclonal antibodies for treating allergy
08/20/2003CN1437472A Highly concentrated stable meloxicam solutions
08/20/2003CN1437469A Solid valsartan pharmaceutical composition
08/20/2003CN1437466A Methods for pulmonary delivery of interleukin-2
08/20/2003CN1437465A Use of an acetylated pre-gelled starch with a high content of amylose
08/20/2003CN1437464A Improved water-insoluble drug particle process
08/20/2003CN1437463A System and method for treating a mucosal surface
08/20/2003CN1437462A Effervescence particles and preparing method thereof
08/20/2003CN1437461A Cosmetic or dermatological cream composition, the preparation and the use thereof
08/20/2003CN1437460A Mousse forming hair treatment composition
08/20/2003CN1437449A Physiologically active agents containing vicinal dithioglycols and use therof in various branches of economy
08/20/2003CN1436558A Plaster for treating pain and swelling
08/20/2003CN1436554A Bupleurum-skullcap dripping pills
08/20/2003CN1436546A Prepn of women's inflammation diminishing film prepn
08/20/2003CN1436536A Effervescent tablet with hyaluronic acid as effective component
08/20/2003CN1436535A Nisoldipine capsule composition
08/20/2003CN1436531A Donepezil hydrochloride dripping pills
08/20/2003CN1436527A Glimepiride dripping pills
08/20/2003CN1436526A Production process and usage of single Chinese herbal medicine extractive granule and powder
08/20/2003CN1436525A Fimbriate orostachys herb suppository and its prepn process
08/20/2003CN1436490A Production process of natural marine organism health food with deep sea clam worm as material
08/20/2003CN1118454C Heterocyclic derivative and medicine
08/20/2003CN1118308C Device for transfermal electrotransporting fentanyl and sufentanil
08/20/2003CN1118301C Bioresorbable oxidized cellulose composite material for prevention of postsurgical adhesions
08/20/2003CN1118296C Balsam pear lozenge and its producing method
08/20/2003CN1118288C Plaster for treating osteomyelitis and trauma
08/20/2003CN1118287C Health-care medicine
08/20/2003CN1118277C Medical aerosol for treating diseases of respiratory system
08/20/2003CN1118250C Composition, cigarette and cigarette filtering tip
08/19/2003US6608054 Pharmaceutical compositions based on anticholinergics and endothelin antagonists
08/19/2003US6608050 Especially from a tin porphyrin and a difatty acid ester of a phosphatidyl choline or glycerol; treatment of cancer and other diseases.
08/19/2003US6607821 Applications and devices based on nanostructured non-stoichiometric substances
08/19/2003US6607784 Microprecipitation method for preparing submicron suspensions
08/19/2003US6607779 Non-stoichiometric non- equilibrium material, and the material is a nanostructured material.
08/19/2003US6607778 Solid delivery systems for aroma ingredients
08/19/2003US6607757 At least 13% glucoside isoflavones and 0.6-1.5 parts 3 soya saponins per 1 part by weight of glucoside isoflavones; treating pre or post menopausal symptoms, breast and prostate cancer, and alcoholism
08/19/2003US6607754 Delivery of Hypericum perforatum (St. John's Wort) in tablet form
08/19/2003US6607752 Forming a nicotine/cation exchange resin solvent mixture by blending nicotine, resin and solvent together, maintaining the solvnet in liquid state for a second by controlling pressure and temperature, then evaporation the solvent
08/19/2003US6607751 Cellulose ether; sustained release
08/19/2003US6607750 Directly compressible acetaminophen compositions
08/19/2003US6607749 Non-fermentable methyl cellulose, lipase inhibitor and edible calcium phosphate salt; fecal incontinence, obesity
08/19/2003US6607748 Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture
08/19/2003US6607747 Spheronized beadlet containing acid labile group is selected from the group consisting of 2', 3'-dideoxyadenosine, 2', 3' dideoxycytidine, pravstatin, erythromycin, digoxin and pancreatin
08/19/2003US6607746 Antimicrobial containing solventless hot melt adhesive composition
08/19/2003US6607745 Ingestion of hyaluronic acid for improved joint function and health
08/19/2003US6607742 Suppository composition which is a spray-dried suspension of an acid-labile proton pump inhibitor in a solvent solution of a sterol and polymer
08/19/2003US6607736 Endermic liniment comprising diethoxy ethyl succinate and humectant
08/19/2003US6607733 Polyethoxylated and/or polypropoxylated oil in water emulsifiers; crosslinking of droplets
08/19/2003US6607722 Methods for inducing the differentiation of monocytes into functional dendritic cells
08/19/2003US6607713 Method for improving UV radiation stability of photosensitive sunscreen filters
08/19/2003US6607382 Methods and systems for concurrent tooth repositioning and substance delivery
08/19/2003CA2280534C Manufacture of cross-linked amylose useful as an excipient for control release of active compounds
08/19/2003CA2138149C Stables compositions of microgranules of gastro-protected omeprazole and process for their preparation
08/19/2003CA2108026C Inhibition of aggregation of drug containing particles
08/19/2003CA2082137C Aliphatic esters as a solventless coating for pharmaceuticals
08/19/2003CA2033122C Anti-inflammatory analgesic patch
08/18/2003CA2372535A1 Antitussive compositions
08/14/2003WO2003066842A2 Method for producing recombinant proteins in micro-organisms
08/14/2003WO2003066824A2 Albumin-fused kunitz domain peptides
08/14/2003WO2003066806A2 Therapeutic use of aziridino compounds
08/14/2003WO2003066712A1 Method for preparation of block copolymeric nanoparticles
08/14/2003WO2003066681A1 Stabilization of protein preparations
08/14/2003WO2003066655A1 Amorphous fluticasone 2-furoate, pharmaceutical compositions thereof and its conversion to the crystalline unsolvated form
08/14/2003WO2003066585A2 Polymer-based compositions for sustained release
08/14/2003WO2003066209A1 Encapsulation process and encapsulated compositions
08/14/2003WO2003066205A2 Microcapsules having high carotenoid content
08/14/2003WO2003066130A2 Transdermal drug delivery systems
08/14/2003WO2003066126A2 Dermal access member
08/14/2003WO2003066123A2 Microinfusion device
08/14/2003WO2003066116A1 Multi-layer dressing as a drug delivery system